IMIDAZOLONYLQUINOLINES AND THE USE THEREOF AS ATM KINASE INHIBITORS
- 专利权人:
- Merck Patent GmbH
- 发明人:
- Thomas FUCHSS,Kai SCHIEMANN
- 申请号：
- US16353559
- 公开号：
- US20190211013A1
- 申请日:
- 2019.03.14
- 申请国别(地区):
- US
- 年份:
- 2019
- 代理人:
- 摘要：
- Compounds of the formula (I), in which R1, R3, Het1 and HET have the meanings given in Claim 1, are ATM kinase inhibitors and can be employed, inter alia, for the treatment of cancer.
- 来源网站：
- 中国工程科技知识中心
